The number of COVID-19 vaccine doses administered in the country has crossed 6.24 crore with 12,94,979 jabs being given on Tuesday, the Union Health Ministry said. A total of 6,24,08,333 vaccine doses have been given till 7 pm on Tuesday, according to a provisional report.
These include 82,00,007 healthcare workers (HCWs) who have taken the first dose and 52,07,368 HCWs who have taken the second dose, 90,08,905 frontline workers (FLWs) who have received the first dose, 37,70,603 FLWs who have taken the second dose. In addition, 2,90,20,989 beneficiaries more than 60 years old received the first dose and 36,899 in the same age bracket got the second dose as well.
As many as71,58,657 beneficiaries aged 45 to 60 with specific co-morbidities were administered the first dose, while 4,905 people in this category received the second dose as well. Total 12,94,979 vaccine doses were given till 7 pm on Tuesday, the seventy-fourth day of the nationwide COVID-19 vaccination drive, the ministry said.
Out of which 11,77,160 beneficiaries were vaccinated for the first dose and 1,17,819 beneficiaries received the second, the ministry said, citing a provisional report compiled at 7 pm. The 11,77,160 beneficiaries who received the first dose on Tuesday include 8,01,732 aged above 60 and 2,86,174 aged 45-60 with comorbidities.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The1,17,819 individuals who received the second dose include 35,316 people aged above 60 years and4,500 individuals aged 45-60 with comorbidities. The countrywide vaccination drive was rolled out on January 16 with healthcare workers getting inoculated and vaccination of the frontline workers started from February 2.The next phase of COVID-19 vaccination has commenced from March 1 for those who are over 60 years of age and for people aged 45 and above with specified co-morbid conditions.